The clinical use of interferons in the management of neuroendocrine gastroenteropancreatic tumors

Ann N Y Acad Sci. 1994 Sep 15:733:471-8. doi: 10.1111/j.1749-6632.1994.tb17297.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Carcinoid Tumor / therapy
  • Humans
  • Interferon Type I / adverse effects
  • Interferon Type I / therapeutic use*
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use*
  • Neuroendocrine Tumors / therapy*
  • Pancreatic Neoplasms / therapy*
  • Recombinant Proteins
  • Stomach Neoplasms / therapy*

Substances

  • Interferon Type I
  • Interferon-alpha
  • Recombinant Proteins